knowledge -WSS

knowledge

author：hotspot 2025-08-26 23:47:45 - browse：65537

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： US intelligence assessment says Iran not currently developing nuclear weapons

explore

WSS

Covid isolation guidance eased by the CDC

AstraZeneca loses challenge to Medicare drug price negotiation

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

US intelligence assessment says Iran not currently developing nuclear weapons

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Rare Northern Lights show in US this week: Where and how to see it

explore

knowledge

knowledge

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Another man arrested in connection with shooting at Kansas nightclub

How to save PrEP access — and even expand it

Covid isolation guidance eased by the CDC

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Congress gives doctors Medicare pay bump

Activists slam private health insurers over coverage restrictions

Neutralizing antibodies against HIV shows promise in children

hotspot

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

How corporate America is slashing DEI workers amid backlash to diversity programs

House looks to weaken Medicare negotiation

In search for therapies for solid tumors, companies turn to claudin

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

explore

explore

entertainment

leisure time